Back to User profile » Prof. Dr. Tobias Welte
Papers published by Prof. Dr. Tobias Welte:
Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET
Stoleriu MG, Pienn M, Joerres RA, Alter P, Fero T, Urschler M, Kovacs G, Olschewski H, Kauczor HU, Wielpütz M, Jobst B, Welte T, Behr J, Trudzinski FC, Bals R, Watz H, Vogelmeier CF, Biederer J, Kahnert K
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:1515-1529
Published Date: 1 July 2024
COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US
Martinez FJ, Papi A, Welte T, Singh D, Galkin DV, Guasconi A, Pirondi S, Georges G, Imperato J, Hermans R
International Journal of Chronic Obstructive Pulmonary Disease 2024, 19:1433-1445
Published Date: 25 June 2024
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Characteristics of Current Smokers versus Former Smokers with COPD and Their Associations with Smoking Cessation Within 4.5 Years: Results from COSYCONET
Alter P, Stoleriu C, Kahnert K, Henke MO, Bals R, Trudzinski FC, Watz H, Speicher T, Söhler S, Welte T, Rabe KF, Wouters EFM, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2911-2923
Published Date: 6 December 2023
![Plain language summary](assets/img/article_icons/plain-language.png)
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]
Laidlaw TM, Menzies-Gow A, Caveney S, Han JK, Martin N, Israel E, Lee JK, Llanos JP, Martin N, Megally A, Parikh B, Vong S, Welte T, Corren J
Journal of Asthma and Allergy 2023, 16:1053-1054
Published Date: 27 September 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
![](cr_data/cache/article_graphical_abstract/s413064/graphical_abstract.jpg)
Laidlaw TM, Menzies-Gow A, Caveney S, Han JK, Martin N, Israel E, Lee JK, Llanos JP, Martin N, Megally A, Parikh B, Vong S, Welte T, Corren J
Journal of Asthma and Allergy 2023, 16:915-932
Published Date: 4 September 2023
Relationship Between the Response to Antibody Therapy and Symptoms of Depression and Anxiety Disorders in Patients with Severe Asthma
Plank PM, Hinze CA, Campbell V, Konwert S, Welte T, Drick N, Kayser MZ, Suhling H, Fuge J
Journal of Asthma and Allergy 2023, 16:421-431
Published Date: 18 April 2023
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Disease Progression and Age as Factors Underlying Multimorbidity in Patients with COPD: Results from COSYCONET
Alter P, Kahnert K, Trudzinski FC, Bals R, Watz H, Speicher T, Söhler S, Andreas S, Welte T, Rabe KF, Wouters EFM, Sassmann-Schweda A, Wirtz H, Ficker JH, Vogelmeier CF, Jörres RA
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:1703-1713
Published Date: 29 July 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Lower Prevalence of Osteoporosis in Patients with COPD Taking Anti-Inflammatory Compounds for the Treatment of Diabetes: Results from COSYCONET
Kahnert K, Jörres RA, Lucke T, Trudzinski FC, Mertsch P, Bickert C, Ficker JH, Behr J, Bals R, Watz H, Welte T, Vogelmeier CF, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3189-3199
Published Date: 24 November 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic
Herth FJF, Sandhaus RA, Turner AM, Sucena M, Welte T, Greulich T
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2983-2996
Published Date: 1 November 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Real-World Multicenter Experience with Mepolizumab and Benralizumab in the Treatment of Uncontrolled Severe Eosinophilic Asthma Over 12 Months
Kayser MZ, Drick N, Milger K, Fuge J, Kneidinger N, Korn S, Buhl R, Behr J, Welte T, Suhling H
Journal of Asthma and Allergy 2021, 14:863-871
Published Date: 12 July 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
Lutter JI, Jörres RA, Trudzinski FC, Alter P, Kellerer C, Watz H, Welte T, Bals R, Kauffmann-Guerrero D, Behr J, Holle R, Vogelmeier CF, Kahnert K
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:987-998
Published Date: 14 April 2021
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients
Janciauskiene S, Royer PJ, Fuge J, Wrenger S, Chorostowska-Wynimko J, Falk C, Welte T, Reynaud-Gaubert M, Roux A, Tissot A, Magnan A
Journal of Inflammation Research 2020, 13:1021-1028
Published Date: 30 November 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma
Drick N, Milger K, Seeliger B, Fuge J, Korn S, Buhl R, Schuhmann M, Herth F, Kendziora B, Behr J, Kneidinger N, Bergmann KC, Taube C, Welte T, Suhling H
Journal of Asthma and Allergy 2020, 13:605-614
Published Date: 11 November 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
Lutter JI, Jörres RA, Welte T, Watz H, Waschki B, Alter P, Trudzinski FC, Ohlander J, Behr J, Bals R, Studnicka M, Holle R, Vogelmeier CF, Kahnert K
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2787-2798
Published Date: 5 November 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA) [Corrigendum]
Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Journal of Asthma and Allergy 2020, 13:135-136
Published Date: 13 March 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)
Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ
Journal of Asthma and Allergy 2020, 13:115-126
Published Date: 17 February 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort
Königsdorfer N, Jörres RA, Söhler S, Welte T, Behr J, Ficker JH, Bals R, Watz H, Lutter JI, Lucke T, Biertz F, Alter P, Vogelmeier CF, Kahnert K
Patient Preference and Adherence 2019, 13:1711-1721
Published Date: 10 October 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Therapy preferences of patients with lung and colon cancer: a discrete choice experiment
Schmidt K, Damm K, Vogel A, Golpon H, Manns MP, Welte T, Graf von der Schulenburg JM
Patient Preference and Adherence 2017, 11:1647-1656
Published Date: 26 September 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Plasminogen activator inhibitor-1 is elevated in patients with COPD independent of metabolic and cardiovascular function
Waschki B, Watz H, Holz O, Magnussen H, Olejnicka B, Welte T, Rabe KF, Janciauskiene S
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:981-987
Published Date: 22 March 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?
Carleo A, Chorostowska-Wynimko J, Koeck T, Mischak H, Czajkowska-Malinowska M, Rozy A, Welte T, Janciauskiene S
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:829-837
Published Date: 8 March 2017
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Dual bronchodilation in COPD: lung function and patient-reported outcomes – a review
Price D, Østrem A, Thomas M, Welte T
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:141-168
Published Date: 30 December 2016